Qureight is an end-to-end imaging CRO on a mission to accelerate clinical trials. We provide enterprise-grade imaging and precision endpoints for the biopharmaceutical industry. Our AI-powered data and imaging curation platform permits the analysis of clinical imaging and other healthcare data from patients with lung and heart disease, helping our customers bring treatments to market, faster.



We provide automated image management and AI analysis in therapeutic areas such as Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Bronchiectasis, and Pulmonary Hypertension. Our world-leading team of scientists, engineers and clinicians is based in Cambridge and London, UK.